Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial

In COVID-19-induced acute respiratory distress syndrome, the lungs are incapable of filling with sufficient air, leading to hypoxemia that results in high mortality among hospitalized patients. In clinical trials, low-molecular-weight heparin was administered via a specially designed soft-mist inhal...

Descripción completa

Detalles Bibliográficos
Autores principales: Erelel, Mustafa, Kaskal, Mert, Akbal-Dagistan, Ozlem, Issever, Halim, Dagistanli, Ahmet Serhan, Balkanci, Hilal, Oguz, Merve Sinem, Qarayeva, Aygun, Culha, Meltem, Erturk, Aybige, Basarir, Nur Sena, Sahin, Gokben, Uresin, Ali Yagiz, Araman, Ahmet Ogul, Medetalibeyoglu, Alpay, Tukek, Tufan, Oncul, Mustafa Oral, Yildiz-Pekoz, Ayca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618458/
https://www.ncbi.nlm.nih.gov/pubmed/34834183
http://dx.doi.org/10.3390/pharmaceutics13111768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618458/
https://www.ncbi.nlm.nih.gov/pubmed/34834183
http://dx.doi.org/10.3390/pharmaceutics13111768

Ejemplares similares